Serological Immunity to Adenovirus serotype 5 is not Associated with Risk of HIV Infection: a Case-control Study

BACKGROUND: Adenoviruses are among the most promising vectors for the development of an HIV vaccine. The results of the phase IIB study of the adenovirus serotype 5-based Merck Trivalent HIV vaccine have raised the concern that serological immunity to Ad5 could be linked to HIV acquisition risk in h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Curlin, Marcel E., Cassis-Ghavami, Farah, Magaret, Amalia, Spies, Greg, Duerr, Ann, Celum, Connie, Sanchez, Jorge, Margolick, Joseph B., Detels, Roger, McElrath, M. Juliana, Corey, Lawrence
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3057418/
https://ncbi.nlm.nih.gov/pubmed/21150554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e328342115c
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados